Obstructive Sleep Apnea as a Risk Marker in Coronary Artery Disease

Study Objectives: Obstructive sleep apnea (OSA) is associated with a range of cardiovascular sequelae and increased cardiovascular mortality. The aim of our study was to assess the prevalence of OSA in patients with symptomatic angina and angiographically verified coronary artery disease (CAD). In addition, we analyzed the association of OSA and other coronary risk factors with CAD and myocardial infarction. Methods: Overnight non-laboratory-monitoring-system recordings for detection of OSA was performed in 223 male patients with angiographically verified CAD and in 66 male patients with exclusion of CAD. A logistic regression analysis was performed to assess associations between risk factors and CAD and myocardial infarction. Results: CAD patients were found to have OSA in 30.5%, whereas OSA was found in control subjects in 19.7%. The mean apnea/hypopnea index (AHI) was significantly higher (p < 0.01) in CAD patients (9.9 ± 11.8) than in control subjects (6.7 ± 7.3). Body-mass-index (BMI) was significantly higher in patients with CAD and OSA than in patients with CAD without OSA (28.1 vs. 26.7 kg/m2; p < 0.001). No significant difference was found with regard to other risk factors and left ventricular ejection fraction (LVEF) between both groups. Hyperlipidemia (OR 2.3; CI 1.3–3.9; p < 0.005) and OSA defined as AHI ≥20 (OR 2.0; CI 1.0–3.8, p < 0.05) were independently associated with myocardial infarction. Conclusions: There is a high prevalence of OSA among patients with angiographically proven CAD. OSA of moderate severity (AHI ≥20) is independently associated with myocardial infarction. Thus, in the care of patients with CAD, particular vigilance for OSA is important.

[1]  T Penzel,et al.  MESAM: a heart rate and snoring recorder for detection of obstructive sleep apnea. , 1990, Sleep.

[2]  B Lüderitz,et al.  Predictive diagnostic value of clinical assessment and nonlaboratory monitoring system recordings in patients with symptoms suggestive of obstructive sleep apnea syndrome. , 1997, Respiration; international review of thoracic diseases.

[3]  D. Blankenhorn,et al.  Arterial wall oxygenation, oxyradicals, and atherosclerosis. , 1991, Atherosclerosis.

[4]  M. Miller,et al.  Disordered breathing and hypoxia during sleep in coronary artery disease. , 1982, Chest.

[5]  J. Kaprio,et al.  Snoring as a risk factor for ischaemic heart disease and stroke in men. , 1987, British medical journal.

[6]  L. Peterson,et al.  High prevalence of hypertension in sleep apnea patients independent of obesity. , 1994, American journal of respiratory and critical care medicine.

[7]  K. Franklin,et al.  Sleep apnoea and nocturnal angina , 1995, The Lancet.

[8]  J. Gainer,et al.  Hypoxia and atherosclerosis: re-evaluation of an old hypothesis. , 1987, Atherosclerosis.

[9]  C Guilleminault,et al.  MESAM 4: an ambulatory device for the detection of patients at risk for obstructive sleep apnea syndrome (OSAS). , 1992, Chest.

[10]  M Partinen,et al.  Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. , 1988, Chest.

[11]  S. Javaheri,et al.  Occult Sleep-Disordered Breathing in Stable Congestive Heart Failure , 1995, Annals of Internal Medicine.

[12]  M. Kryger,et al.  Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. , 1988, Chest.

[13]  T. Rabben,et al.  Sleep-disordered breathing in men with coronary artery disease. , 1996, Chest.

[14]  C. Guilleminault,et al.  Leftward shift of the interventricular septum and pulsus paradoxus in obstructive sleep apnea syndrome. , 1991, Chest.

[15]  J. Ringler,et al.  Hemodynamic consequences of obstructive sleep apnea. , 1996, Sleep.

[16]  T. Rabben,et al.  Sleep-disordered breathing in women: occurrence and association with coronary artery disease. , 1996, The American journal of medicine.

[17]  David Watts.  Apnea , 1997, The Lancet.

[18]  S. Redline,et al.  Measurement of sleep-related breathing disturbances in epidemiologic studies. Assessment of the validity and reproducibility of a portable monitoring device. , 1991, Chest.

[19]  J. Peter,et al.  Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. , 1997, Chest.

[20]  C. Zwillich,et al.  Possible atherogenic effects of hypoxia during obstructive sleep apnea. , 1993, Sleep.

[21]  J Sellgren,et al.  Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. , 1993, Chest.

[22]  D. Hillman,et al.  Association of sleep apnoea with myocardial infarction in men , 1990, The Lancet.

[23]  J. Kaprio,et al.  SNORING AS A RISK FACTOR FOR HYPERTENSION AND ANGINA PECTORIS , 1985, The Lancet.

[24]  T. Young,et al.  The occurrence of sleep-disordered breathing among middle-aged adults. , 1993, The New England journal of medicine.

[25]  S. Redline,et al.  Recognition of obstructive sleep apnea. , 1996, American journal of respiratory and critical care medicine.

[26]  E. Fletcher,et al.  The relationship between systemic hypertension and obstructive sleep apnea: facts and theory. , 1995, The American journal of medicine.